|
1
|
Arnold M, Rutherford MJ, Bardot A, Ferlay
J, Andersson TM, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D,
Shack L, et al: Progress in cancer survival, mortality, and
incidence in seven high-income countries 1995–2014 (ICBP
SURVMARK-2): A population-based study. Lancet Oncol. 20:1493–1505.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bindea G, Mlecnik B, Tosolini M,
Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T,
Lafontaine L, Berger A, et al: Spatiotemporal dynamics of
intratumoral immune cells reveal the immune landscape in human
cancer. Immunity. 39:782–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schumacher TN and Schreiber RD:
Neoantigens in cancer immunotherapy. Science. 348:69–74. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Topalian SL, Drake CG and Pardoll DM:
Immune checkpoint blockade: A common denominator approach to cancer
therapy. Cancer Cell. 27:450–461. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Becht E, Giraldo NA, Dieu-Nosjean MC,
Sautès-Fridman C and Fridman WH: Cancer immune contexture and
immunotherapy. Curr Opin Immunol. 39:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blanco MA, Alečković M, Hua Y, Li T, Wei
Y, Xu Z, Cristea IM and Kang Y: Identification of staphylococcal
nuclease domain-containing 1 (SND1) as a Metadherin-interacting
protein with metastasis-promoting functions. J Biol Chem.
286:19982–19992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky
DJ and Fisher PB: Cloning and characterization of HIV-1-inducible
astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee SG, Kang DC, DeSalle R, Sarkar D and
Fisher PB: AEG-1/MTDH/LYRIC, the beginning: Initial cloning,
structure, expression profile, and regulation of expression. Adv
Cancer Res. 120:1–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoo BK, Emdad L, Lee SG, Su ZZ,
Santhekadur P, Chen D, Gredler R, Fisher PB and Sarkar D: Astrocyte
elevated gene-1 (AEG-1): A multifunctional regulator of normal and
abnormal physiology. Pharmacol Ther. 130:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu HY, Liu CX, Han B, Zhang XY and Sun
RP: AEG-1 is associated with clinical outcome in neuroblastoma
patients. Cancer Biomark. 11:115–121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Subramanian A, Kuehn H, Gould J, Tamayo P
and Mesirov JP: GSEA-P: A desktop application for gene set
enrichment analysis. Bioinformatics. 23:3251–3253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tokunaga E, Nakashima Y, Yamashita N,
Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M and
Maehara Y: Overexpression of metadherin/MTDH is associated with an
aggressive phenotype and a poor prognosis in invasive breast
cancer. Breast Cancer. 21:341–349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng X, Brachova P, Yang S, Xiong Z, Zhang
Y, Thiel KW and Leslie KK: Knockdown of MTDH sensitizes endometrial
cancer cells to cell death induction by death receptor ligand TRAIL
and HDAC inhibitor LBH589 co-treatment. PLoS One. 6:e209202011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng X, Thiel KW and Leslie KK: Drug
resistance mediated by AEG-1/MTDH/LYRIC. Adv Cancer Res.
120:135–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Heo J, Lim CK, Whang DR, Shin J, Jeong SY,
Park SY, Kwon IC and Kim S: Self-deprotonation and colorization of
1,3-bis(dicyanomethylidene)indan in polar media: A facile route to
a minimal polymethine dye for NIR fluorescence imaging. Chemistry.
18:8699–8704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Emdad L, Das SK, Dasgupta S, Hu B, Sarkar
D and Fisher PB: AEG-1/MTDH/LYRIC: signaling pathways, downstream
genes, interacting proteins, and regulation of tumor angiogenesis.
Adv Cancer Res. 120:75–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goldman M, Craft B, Hastie M, Repečka K,
McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al:
The UCSC Xena platform for public and private cancer genomics data
visualization and interpretation. bioRxiv. 3264702019.
|
|
20
|
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q,
Li B and Liu XS: TIMER2.0 for analysis of tumor-infiltrating immune
cells. Nucleic Acids Res. 48((W1)): W509–W514. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szklarczyk D, Gable AL, Nastou KC, Lyon D,
Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al:
The STRING database in 2021: Customizable protein-protein networks,
and functional characterization of user-uploaded gene/measurement
sets. Nucleic Acids Res. 49((D1)): D605–D612. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liao Y, Wang J, Jaehnig EJ, Shi Z and
Zhang B: WebGestalt 2019: Gene set analysis toolkit with revamped
UIs and APIs. Nucleic Acids Res. 47((W1)): W199–W205. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ogłuszka M, Orzechowska M, Jędroszka D,
Witas P and Bednarek AK: Evaluate Cutpoints: Adaptable continuous
data distribution system for determining survival in Kaplan-Meier
estimator. Comput Methods Programs Biomed. 177:133–139. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y,
Zhou R, Qiu W, Huang N, Sun L, et al: IOBR: multi-omics
immuno-oncology biological research to decode tumor
microenvironment and signatures. Front Immunol. 12:6879752021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He J, Ding H, Li H, Pan Z and Chen Q:
Intra-tumoral expression of SLC7A11 is associated with immune
microenvironment, drug resistance, and prognosis in cancers: A
pan-cancer analysis. Front Genet. 12:7708572021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li L, Yao W, Yan S, Dong X, Lv Z, Jing Q,
Wang Q, Ma B, Hao C, Xue D and Wang D: Pan-cancer analysis of
prognostic and immune infiltrates for CXCs. Cancers (Basel.
13:41532021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stenström J, Hedenfalk I and Hagerling C:
Regulatory T lymphocyte infiltration in metastatic breast cancer-an
independent prognostic factor that changes with tumor progression.
Breast Cancer Res. 23:272021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ren L, Yi J, Yang Y, Li W, Zheng X, Liu J,
Li S, Yang H, Zhang Y, Ge B, et al: Systematic pan-cancer analysis
identifies APOC1 as an immunological biomarker which regulates
macrophage polarization and promotes tumor metastasis. Pharmacol
Res. 183:1063762022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shan L, Lu Y, Song Y, Zhu X, Xiang CC, Zuo
ED and Cheng X: Identification of nine M6A-related long noncoding
RNAs as prognostic signatures associated with oxidative stress in
oral cancer based on data from the cancer genome atlas. Oxid Med
Cell Longev. 2022:95298142022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Niwa N, Tanaka N, Hongo H, Miyazaki Y,
Takamatsu K, Mizuno R, Kikuchi E, Mikami S, Kosaka T and Oya M:
TNFAIP2 expression induces epithelial-to-mesenchymal transition and
confers platinum resistance in urothelial cancer cells. Lab Invest.
99:1702–1713. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiao Y, Yang H, Qian J, Gong Y, Liu H, Wu
S, Cao L and Tang L: miR-3664-5P suppresses the proliferation and
metastasis of gastric cancer by attenuating the NF-κB signaling
pathway through targeting MTDH. Int J Oncol. 54:845–858.
2019.PubMed/NCBI
|
|
33
|
Luo L, Tang H, Ling L, Li N, Jia X, Zhang
Z, Wang X, Shi L, Yin J, Qiu N, et al: LINC01638 lncRNA activates
MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation
in triple-negative breast cancer. Oncogene. 37:6166–6179. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qin Y, Wang J, Zhu G, Li G, Tan H, Chen C,
Pi L, She L, Chen X, Wei M, et al: CCL18 promotes the metastasis of
squamous cell carcinoma of the head and neck through MTDH-NF-κB
signalling pathway. J Cell Mol Med. 23:2689–2701. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yin Q, Han Y, Zhu D, Li Z, Shan S, Jin W,
Lu Q and Ren T: miR-145 and miR-497 suppress TGF-β-induced
epithelial-mesenchymal transition of non-small cell lung cancer by
targeting MTDH. Cancer Cell Int. 18:1052018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu C, Liu Y and Qin Z: Metadherin
contributes to epithelial-mesenchymal transition and paclitaxel
resistance induced by acidic extracellular pH in nasopharyngeal
carcinoma. Oncol Lett. 15:3858–3863. 2018.PubMed/NCBI
|
|
37
|
Li J, Li C, Li H, Zhang T, Hao X, Chang J
and Xu Y: MicroRNA-30a-5p suppresses tumor cell proliferation of
human renal cancer via the MTDH/PTEN/AKT pathway. Int J Mol Med.
41:1021–1029. 2018.PubMed/NCBI
|
|
38
|
Zhang F, Huang H, Qin Y, Chen C, She L,
Wang J, Huang D, Tang Q, Liu Y, Zhu G and Zhang X: MTDH associates
with m6A RNA methylation and predicts cancer response for immune
checkpoint treatment. iScience. 24:1031022021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang H, Dai Z, Wu W, Wang Z, Zhang N,
Zhang L, Zeng WJ, Liu Z and Cheng Q: Regulatory mechanisms of
immune checkpoints PD-L1 and CTLA-4 in cancer. J Exp Clin Cancer
Res. 40:1842021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Esfahani K, Roudaia L, Buhlaiga N, Del
Rincon SV, Papneja N and Miller WH Jr: A review of cancer
immunotherapy: From the past, to the present, to the future. Curr
Oncol. 27 (Suppl 2):S87–S97. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang H, Luo YB, Wu W, Zhang L, Wang Z,
Dai Z, Feng S, Cao H, Cheng Q and Liu Z: The molecular feature of
macrophages in tumor immune microenvironment of glioma patients.
Comput Struct Biotechnol J. 19:4603–4618. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang H, Wang Z, Dai Z, Wu W, Cao H, Li S,
Zhang N and Cheng Q: Novel Immune Infiltrating cell signature based
on cell pair algorithm is a prognostic marker in cancer. Front
Immunol. 12:6944902021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hiam-Galvez KJ, Allen BM and Spitzer MH:
Systemic immunity in cancer. Nat Rev Cancer. 21:345–359. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Josefowicz SZ, Lu LF and Rudensky AY:
Regulatory T cells: Mechanisms of differentiation and function.
Annu Rev Immunol. 30:531–564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li C, Jiang P, Wei S, Xu X and Wang J:
Regulatory T cells in tumor microenvironment: New mechanisms,
potential therapeutic strategies and future prospects. Mol Cancer.
19:1162020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen Y, Song Y, Du W, Gong L, Chang H and
Zou Z: Tumor-associated macrophages: An accomplice in solid tumor
progression. J Biomed Sci. 26:782019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Duan Z and Luo Y: Targeting macrophages in
cancer immunotherapy. Signal Transduct Target Ther. 6:1272021.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yin M, Li X, Tan S, Zhou HJ, Ji W, Bellone
S, Xu X, Zhang H, Santin AD, Lou G and Min W: Tumor-associated
macrophages drive spheroid formation during early transcoelomic
metastasis of ovarian cancer. J Clin Invest. 126:4157–4173. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mantovani A, Marchesi F, Malesci A, Laghi
L and Allavena P: Tumour-associated macrophages as treatment
targets in oncology. Nat Rev Clin Oncol. 14:399–416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Galli F, Aguilera JV, Palermo B, Markovic
SN, Nisticò P and Signore A: Relevance of immune cell and tumor
microenvironment imaging in the new era of immunotherapy. J Exp
Clin Cancer Res. 39:892020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Manna D and Sarkar D: Multifunctional role
of astrocyte elevated gene-1 (AEG-1) in cancer: Focus on drug
resistance. Cancers (Basel). 13:17922021. View Article : Google Scholar : PubMed/NCBI
|
